Proteomics International Laboratories (PIQ)
Proteomics International Laboratories Ltd. is a biological research and drug discovery company. It operates through three synergistic business units: Analytical services, Diagnostics and Therapeutics. The Analytical services unit engages in contract research, analytical testing and consultancy. The Diagnostics unit is a biomarkers of disease and personalised medicine. The Therapeutics unit includes peptide drug discovery from venoms. The company was founded by Richard Lipscombe and Bill Parker on June 09, 2014 and is headquartered in Perth, Australia.
|Market Price at 17-01-2018||$0.30|
|Price to Earnings Ratio||-10.18|
|Market Capitalisation||$17.70 (million)|
|Return on Equity (ROE)||-57.14%|